Connect with us

Featured

Liberty Defense (SCAN.V) to Collaborate with FC Bayern München to Beta Test HEXWAVE

Joe Samuel

Published

on

stock market news

VANCOUVER and MÜNCHEN, Germany, June 17, 2019 /PRNewswire/ – Liberty Defense Holdings, Ltd. (“Liberty”) (TSXV: SCAN; FRANKFURT: LD2), a leader in security and weapons detection solutions, is pleased to announce that the company has signed a Memorandum of Understanding (“MOU”) with the German soccer team, FCBayern München (“FC Bayern”), a German football club based in Munich, Bavaria (“Bayern”) to beta test HEXWAVE.

Allianz Arena, the home of FC Bayern, has a 75,000-seating capacity and is the second largest arena in Germany.

HEXWAVE uses low-power, radar imaging and artificial intelligence primarily to detect and identify weapons, while enabling a layered defense strategy for a venue, meaning the ability to detect threats at the perimeter of the property without obstructing the movement of large groups of people.

“The reception to our HEXWAVE product has been fantastic and we are excited about working alongside FC Bayern Munich, a team that is a household name in both Europe and North America,” said Bill Riker, CEO of Liberty Defense. “Our ability to deploy in both indoor and outdoor settings, with covert and overt applications, sets us apart and has also been driving increasing interest from the market.”

Product testing in actual facilities, in partnership with organizations such as FC Bayern, are a crucial part of the product development process for HEXWAVE to ensure that the product is aligned to market requirements. Testing in Europe will likely take place following the initial testing in North America.

Beta testing involves testing HEXWAVE in a live environment with the initial Alpha testing to occur at Liberty’s Center of Excellence laboratory in Atlanta, Georgia.

Oliver Meßthaler, head of security FC Bayern München said, “We look forward to working with Liberty Defense to assess the capabilities of the HEXWAVE product.”

“We are pleased to have the opportunity to work with FC Bayern and have them sign on to become the first early adopter in Europe of this advanced technology,” added Riker.

The weapons detections systems market size is expected to reach over US$7.5 billion by 2025, up from US$4.9 billion today, with public venues such as stadiums comprising 20% of the market. Europe alone is expected to make up 24% of this global market, according to a 2018 report from Homeland Security Research Corp.

On Behalf of Liberty Defense
Bill Riker
CEO & Director

About Liberty Defense
Liberty provides security solutions for concealed weapon detection in high volume foot traffic areas and has secured an exclusive license from Massachusetts Institute of Technology (MIT), as well as a technology transfer agreement, for patents related to active 3D radar imaging technology that are packaged into the HEXWAVE product. The system is designed to provide discrete, modular and scalable protection to provide layered, stand-off detection capability. This is intended to provide a means to proactively counter evolving urban threats. The sensors with active 3D radar imaging and Artificial Intelligence (AI)-enhanced automatic detection are designed to detect metallic and non-metallic firearms, knives, explosives and other threats. Liberty is committed to protecting communities and preserving peace of mind through superior security detection solutions. Learn more: LibertyDefense.com

About FC Bayern München
Football-Club Bayern München AG., commonly known as FC Bayern München, FCB, Bayern Munich, or FC Bayern, is a German sports club based in Munich, Bavaria (Bayern). It is best known for its professional football team, which plays in the Bundesliga, the top tier of the German football league system, and is the most successful club in German football history, having won a record 29 national titles and 19 national cups. Allianz Arena has a 75,000 seating capacity and is the second largest arena in Germany.

FORWARD-LOOKING STATEMENTS

When used in this press release, the words “estimate”, “project”, “belief”, “anticipate”, “intend”, “expect”, “plan”, “predict”, “may” or “should” and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although Liberty believes, in light of the experience of their respective officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in the forward-looking statements and information in this press release are reasonable, undue reliance should not be placed on them because the parties can give no assurance that such statements will prove to be correct. The forward-looking statements and information in this press release include, amongst others, information relating to the expectation for development of HEXWAVE and future Beta testing. Such statements and information reflect the current view of Liberty. There are risks and uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and information.

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the development of HEXWAVE and future Beta testing. These fluctuations may adversely affect the price of the Liberty’s securities, regardless of its operating performance. There are a number of important factors that could cause Liberty’s actual results to differ materially from those indicated or implied by forward-looking statements and information. Such factors include, among others: currency fluctuations; limited business history of the parties; disruptions or changes in the credit or security markets; results of operation activities and development of projects; project cost overruns or unanticipated costs and expenses; and general market and industry conditions. The parties undertake no obligation to comment on analyses, expectations or statements made by third parties in respect of their securities or their respective financial or operating results (as applicable).

Liberty cautions that the foregoing list of material factors is not exhaustive. When relying on Liberty’s forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Liberty has assumed that the material factors referred to in the previous paragraph will not cause such forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.

The forward-looking information contained in this press release represents the expectations of Liberty as of the date of this press release and, accordingly, are subject to change after such date. Liberty does not undertake to update this information at any particular time except as required in accordance with applicable laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Continue Reading
Click to comment

Featured

Stock Price Newsletter – November 22, 2019

Joe Samuel

Published

on

stock price newsletter

Active Biotech Stocks To Watch As Markets Flirt With New Highs

Biotech stocks are often regarded as safe due to the simple fact that it is a sector that has grown across the board for quite some time. However, in addition, the biotech sector has the potential to generate handsome gains if an investor ends up choosing the right stock.

Click Here To Read More


Streaming Stocks Take Aim At Winning The Content War

The emergence of competition for streaming services from other corporate giants like Disney has started to raise eyebrows. It has been projected that the industry is going to be worth $124.57 billion by 2025. That being said, there may be ample opportunity for investors. Here is a look at a few tech stocks to watch that could be set to prove themselves on this new battlefield.

See For Yourself


Defense Stocks in Focus This Week

It is a well-known fact that the United States has the biggest defense budget in the world and the budget rises every year. That’s is why defense stocks are almost always in demand. These are companies that often win mega contracts from the American government and are immune from the volatile swings of the market.

Continue Reading

Continue Reading

Biotechnology

Active Biotech Stocks To Watch As Markets Flirt With New Highs

A. Lawrence

Published

on

biotech stocks to watch

Biotech stocks is often regarded as safe due to the simple fact that it is a sector that has grown across the board for quite some time. However, in addition, the biotech sector has the potential to generate handsome gains if an investor ends up choosing the right stock.

Investors need to watch the market closely and be aware of the latest news from the sector in order to make the best choices. Here is a look at 3 biotech stocks that turned heads in the biotech sector this week.

PharmaCyte Biotech (PMCB)

PharmaCyte Biotech (PMCB) is in the prep phase of clinical trials and readying to complete its Investigational New Drug Application for the FDA.  Whether you’re new to biotech stocks or a seasoned vet, you should understand how important milestones like this are for a company.

David A. Judd, a cellular biologist and a member of PharmaCyte’s Medical and Scientific Advisory Board, was recently interviewed. Right now, PharmaCyte Biotech (PMCB) is putting together the necessary material for its planned clinical trial for inoperable pancreatic cancer, one of the most deadly forms of cancer today. Though there has been a targeted focus on Pancreatic cancer with PharmaCyte, its diabetes application may also have promise according to Judd.

“I think diabetes is where this type of technology really lends itself to the application. The key is to develop the right type of cell line to treat Type 1 and insulin-dependent Type 2 diabetes. There are several cell lines being explored by PharmaCyte simultaneously to do this. Selecting the right cell line to become our leading product candidate to treat diabetic patients in need of insulin is key to the success of PharmaCyte’s Diabetes Program.”

As one report puts it, “Clinical trials are essential for the development of new treatments, and PharmaCyte will enter this upcoming trial with two essential goals in mind—the future of its pancreatic cancer treatment and the future of its technology.”

For more on PharmaCyte, Click Here

VIVUS (VVUS)

The first biotech stock to consider here is that of VIVUS, Inc. (NASDAQ:VVUS), which has rallied on Wednesday on the back of a major announcement from the company. The stock rallied by 3% this morning in premarket trade after the results were announced from the Phase 1 clinical trial of its product Qsymia. The medicine in question is a capsule and is meant for people who suffer from binge eating disorder.

It should be noted that medicine is currently approved in the United States when used by people in order to reduce calories in their diets. It is a major development for VIVUS and it is no surprise that the stock rallied today.

Diffusion Pharmaceuticals (DFFN)

The other biotech stock that is worth including in the watch list is that of Diffusion Pharmaceuticals Inc (NASDAQ:DFFN), which made solid gains yesterday on the back of the announcement of positive preliminary data from the Phase 3 clinical trial of Trans Sodium Crocetinate (TSC). The medicine is meant for treating inoperable glioblastoma and in the results, it has been revealed that patients recorded a median survival duration of as long as 14.3 months.

Historically, the standard survival duration is only 9.2 months. The results triggered a rally in the stock and the Diffusion stock soared by as much as 67.60%.

list of healthcare stocks to watch

Disclaimer: Pursuant to an agreement between MIDAM VENTURES, LLC and Complete Investment And Management LLC, a Non-affiliate Third Party, Midam was hired for a period from 07/09/2019 – 8/09/2019 to publicly disseminate information about PharmaCyte Biotech including on the Website and other media including Facebook and Twitter. We were paid $150,000 (CASH) for & were paid “0” shares of restricted common shares. We were paid an additional $150,000 (CASH) BY Complete Investment And Management LLC, a Non-affiliate Third Party, AND HAVE EXTENDED coverage for a period from 8/12/2019 – 10/15/2019. We were paid an additional $150,000 (CASH) BY Complete Investment And Management LLC, a Non-affiliate Third Party, AND HAVE EXTENDED coverage for a period from 10/16/2019 – 11/15/2019.We may buy or sell additional shares of PharmaCyte Biotech in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click Here For Full Disclaimer.

Continue Reading

Featured

Defense Stocks in Focus This Week

Joe Samuel

Published

on

defense stocks to watch weapons detection

While Many Watch Marijuana Stocks, Defense Gets Another Push

It is a well-known fact that the United States has the biggest defense budget in the world and the budget rises every year. That’s is why defense stocks are almost always in demand. These are companies that often win mega contracts from the American government and are immune from the volatile swings of the market.

Even if the economic situation is weak, the government will continue to spend on defense. Therefore these stocks are so attractive for investors. Here is a look at three penny stocks that are worth tracking at this point in time.

Liberty Defense Holdings (SCAN.V) (LDDFF)

There have been more mass shootings this year in the United States than there have been days in the year. Over 330 mass shootings [1], to be exact. This is becoming a huge issue that is costing precious lives and could see billions of dollars spent to fix this situation.

Liberty Defense (TSX: SCAN.V) (OTC: LDDFF) plans to address this issue using HEXWAVE, a next-generation high-tech security scanning system. It will use advanced, low-power radar, 3D-imaging, and Artificial Intelligence (AI) to screen people at public gatherings such as sports games, unobtrusively. The company itself has been making paramount progress this quarter.

Most recently the company signed a collaboration agreement with Port Tampa Bay to beta test HEXWAVE. Between the years 2007 and 2017, total cruise ship passenger capacity grew by 25 percent in North America, with the following 10 years estimated to see a further 41 percent increase, according to a 2017 report. So this move could prove to be well-timed for a company like Liberty Defense (TSX: SCAN.V) (OTC: LDDFF).

Also, keep in mind that they’ve also got agreements in place with FC Bayern Munich’s Allianz Arena in Germany, Rogers Arena in Vancouver, British Columbia, Maryland Stadium Authority’s Camden Yards Complex, and in the state of Utah. There’s also projects with the Virginia Division of Capitol Police, in Sleiman shopping centers, in a Hindu temple, in the Metro Toronto Convention Centre, in Toronto Pearson International Airport, and with the University of Wisconsin Police Department. To say that they’ve laid the groundwork may be an understatement and results of these beta tests are highly anticipated by the company.

Air Industries Group (AIRI)

The first defense stock to consider is that of Air Industries Group Inc (NYSEAMERICAN:AIRI). The company is involved in aerospace and defense space. Air is best known for manufacturing, designing and selling products that are meant for flight safety. The Air stock has done particularly well this year and has soared by as much as 65% thus far. It is important to point out that Air counts some of the biggest names in the industry among its clients.

Products made by the company are currently used in Sikorsky’s UH-60 Black Hawk, Lockheed Martin’s F-35 Joint Strike Fighter, Northrop Grumman’s E2 Hawkeye, Boeing’s 777, Airbus’ 380 commercial airliners, and the US Navy F-18 and USAF F-16 fighter aircraft. It also supplies equipment for different United States State Department Branches. It goes without saying that this is a stock that should be tracked closely.

Astrotech Corp (ASTC)

The other defense stock that should be in investors’ watch lists is that of Astrotech Corp (NASDAQ:ASTC). On November 14, it emerged that a product made by the company’s subsidiary 1st Detect has been chosen to conduct live screening at Miami International Airport by the U.S.

Department of Homeland Security (DHS) Transportation Security Administration (TSA). The product in question is TRACER 1000 and ever since the announcement was made, there has been an impressive rally in the Astrotech stock. That stock rallied by as much as 80% in one day.

weapons detection stocks security stocks

Disclaimer:Pursuant to an agreement between MIDAM VENTURES, LLC and Liberty Defense Holdings Inc. Midam was hired for a period from 06/1/2019 – 9/30/2019 to publicly disseminate information about Liberty Defense Holdings Inc. including on the Website and other media including Facebook and Twitter. We were paid $250,000 (CASH) for & were paid “0” shares of restricted common shares. We were paid $75,000 (CASH) by Liberty Defense Holdings AND HAVE EXTENDED coverage for a period from 11/1/2019 – 11/30/2019. We may buy or sell additional shares of Liberty Defense Holdings Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. For previous compensation see our FULL DISCLAIMER HERE.

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


Privacy Policy

We keep all user information pricate & promise to never spam.*

Stock Price Free Text List

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com